Correction to: Scientific Reports https://doi.org/10.1038/s41598-022-06523-x, published online 15 February 2022
The Funding section in the original version of this Article was omitted. The Funding section now reads:
“We acknowledge the support the European Social Fund (ESF), reference: ESF/14-BM-A55-0002/18, and the Ministry of Education, Science and Culture of Mecklenburg-Vorpommern, Germany for the joint research project ONKOTHER-H.”
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Rebl, H., Sawade, M., Hein, M. et al. Publisher Correction: Synergistic effect of plasma-activated medium and novel indirubin derivatives on human skin cancer cells by activation of the AhR pathway. Sci Rep 12, 4341 (2022). https://doi.org/10.1038/s41598-022-08218-9
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-022-08218-9
